131 related articles for article (PubMed ID: 3885580)
1. [Considerations on the therapeutic use of monoclonal antibodies].
Knapp W; Majdic O; Holter W; Stockinger H; Köller U
Wien Klin Wochenschr; 1985 Feb; 97(3):97-107. PubMed ID: 3885580
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic and therapeutic use of monoclonal antibodies].
Grunow R; Volk HD; von Baehr R
Z Gesamte Inn Med; 1985 Sep; 40(18):529-31. PubMed ID: 2416138
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies: the possibilities for cancer therapy.
Poynton CH; Reading CL
Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies in research and clinical medicine].
Voigt A
Kinderarztl Prax; 1989 Oct; 57(10):479-87. PubMed ID: 2689756
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic concepts in clinical organ transplantation: histocompatibility testing and T cell monitoring.
Wonigeit K
J Clin Chem Clin Biochem; 1984 Dec; 22(12):959-67. PubMed ID: 6396372
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies and their potential application to medicine].
Weber S
Z Erkr Atmungsorgane; 1985; 165(1):3-12. PubMed ID: 2414929
[TBL] [Abstract][Full Text] [Related]
8. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
[TBL] [Abstract][Full Text] [Related]
9. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
[No Abstract] [Full Text] [Related]
10. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
11. In vivo T cell activation properties of anti-T cell monoclonal antibodies.
Ferran C; Bach JF; Chatenoud L
Exp Nephrol; 1993; 1(2):83-9. PubMed ID: 8081961
[TBL] [Abstract][Full Text] [Related]
12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
[No Abstract] [Full Text] [Related]
14. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
16. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
[TBL] [Abstract][Full Text] [Related]
17. Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen.
Burns GF; Boyd AW; Beverley PC
J Immunol; 1982 Oct; 129(4):1451-7. PubMed ID: 6980937
[TBL] [Abstract][Full Text] [Related]
18. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
Cobbold SP; Thierfelder S; Waldmann H
Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
